SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
SAMHSA Warns of Growing Threat from Xylazine
Ann Tucker
top of page
Search
Recent Posts
See AllSAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911 to help in better understanding the...
Bloomberg Government [9/09] - The Biden administration is poised to issue a final rule toughening mandates for employer-sponsored health...
Forbes [7/09] - Purdue Pharma went back to court this week after the Supreme Court thwarted the OxyContin maker’s...
bottom of page
Commenti